A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Clinical trial NCT05313282 · UNKNOWN

Trial details

NCT number: NCT05313282
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

C-staged Hepatocellular Carcinoma in BCLC Classification

Start date: 2022-06-15
Primary completion: 2024-11-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.